LCA0001

Des(benzylpyridyl) Atazanavi

1192224-24-0

LCA0002

LY-2608204

1234703-40-2

LCA0003

SNS314

1146618-41-8

LCA0004

XL388

1251156-08-7

LCA0005

XL-765

1349796-36-6

LCA0006

(+)-Cloprostenol

54276-21-0

LCA0007

(+)-Cloprostenol Sodium

62561-03-9

LCA0008

(+)-JQ-1

1268524-70-4

LCA0009

(±)-SLV 319

362519-49-1

LCA0010

(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol

188399-48-6

LCA0011

MK-3102 (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2H,4H,6H)-yl)tetrahydro-2H-pyran-3-amine

1226781-44-7

LCA0012

Gefitinib (3-Chloro-4-fluoro-phenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazolin-4-yl]-amine

184475-35-2

LCA0013

LY2623091 (E)-1-(5-((E)-(3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)methyl)-1-((R)-1-morpholinopropan-2-yl)-1H-benzo[d]imidazol-2(3H)-ylidene)urea

1162264-07-4

LCA0014

(E)-5-(2-(1H-indol-4-yl)vinyl)-N-(4-(piperidin-4-ylsulfonyl)phenyl)pyrimidin-2-amine

LCA0016

Dacomitinib (PF299804) (E)-N-(4-(3-chloro-4-fluorophenylamino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide

1110813-31-4

LCA0018

(R)-1-(3,6-dibromo-9H-carbazol-9-yl)-3-(3-methoxyphenylamino)propan-2-ol

1235481-43-2

LCA0019

Almorexant (R)-2-((S)-6,7-dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide

871224-63-4

LCA0020

(R)-4-(4-(4-(2H-1,2,3-triazol-2-yl)phenyl)-2-oxopyridin-1(2H)-yl)-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide

1312473-81-6

LCA0021

PF-04753299 (LpxC inhibitor 1a) (2R)-4-Biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide

1289620-49-0

LCA0022

(R)-5-(3-tert-butyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-yl)-3-(4-fluorophenyl)-1,2,4-oxadiazole